These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31227582)

  • 21. DIAGNOSIS OF ENDOCRINE DISEASE: Post-pancreatitis diabetes mellitus: prime time for secondary disease.
    Petrov MS
    Eur J Endocrinol; 2021 Apr; 184(4):R137-R149. PubMed ID: 33460393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes.
    Dugic A; Hagström H; Dahlman I; Rutkowski W; Daou D; Kulinski P; Löhr JM; Vujasinovic M
    United European Gastroenterol J; 2023 Feb; 11(1):79-91. PubMed ID: 36454055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.
    Johnson JA; Majumdar SR; Simpson SH; Toth EL
    Diabetes Care; 2002 Dec; 25(12):2244-8. PubMed ID: 12453968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
    Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
    Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin may improve the prognosis of patients with pancreatic cancer.
    Zhang JW; Sun Q
    Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study.
    Yen FS; Hsu CC; Su YC; Wei JC; Hwu CM
    Medicine (Baltimore); 2021 Mar; 100(9):e25085. PubMed ID: 33655987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
    Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
    Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.
    Beckmann K; Crawley D; Nordström T; Aly M; Olsson H; Lantz A; Binti Abd Jalal N; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
    JAMA Netw Open; 2019 Nov; 2(11):e1914689. PubMed ID: 31693126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
    Pusceddu S; Vernieri C; Di Maio M; Marconcini R; Spada F; Massironi S; Ibrahim T; Brizzi MP; Campana D; Faggiano A; Giuffrida D; Rinzivillo M; Cingarlini S; Aroldi F; Antonuzzo L; Berardi R; Catena L; De Divitiis C; Ermacora P; Perfetti V; Fontana A; Razzore P; Carnaghi C; Davì MV; Cauchi C; Duro M; Ricci S; Fazio N; Cavalcoli F; Bongiovanni A; La Salvia A; Brighi N; Colao A; Puliafito I; Panzuto F; Ortolani S; Zaniboni A; Di Costanzo F; Torniai M; Bajetta E; Tafuto S; Garattini SK; Femia D; Prinzi N; Concas L; Lo Russo G; Milione M; Giacomelli L; Buzzoni R; Delle Fave G; Mazzaferro V; de Braud F
    Gastroenterology; 2018 Aug; 155(2):479-489.e7. PubMed ID: 29655834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
    Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
    Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.
    Lu Y; García Rodríguez LA; Malgerud L; González-Pérez A; Martín-Pérez M; Lagergren J; Bexelius TS
    Br J Cancer; 2015 Dec; 113(11):1607-14. PubMed ID: 26575601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes.
    Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A
    Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study.
    Andersson C; Olesen JB; Hansen PR; Weeke P; Norgaard ML; Jørgensen CH; Lange T; Abildstrøm SZ; Schramm TK; Vaag A; Køber L; Torp-Pedersen C; Gislason GH
    Diabetologia; 2010 Dec; 53(12):2546-53. PubMed ID: 20838985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.
    Chang YC; Chuang LM; Lin JW; Chen ST; Lai MS; Chang CH
    Diabet Med; 2015 Nov; 32(11):1460-9. PubMed ID: 25970814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):18802-18810. PubMed ID: 27861146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users.
    Gamble JM; Thomas JM; Twells LK; Midodzi WK; Majumdar SR
    Medicine (Baltimore); 2016 Jun; 95(26):e3995. PubMed ID: 27368005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.